In today's session, these stocks are experiencing unusual volume.
By Mill Chart
Last update: May 8, 2024
Unusual volume stocks in Wednesday's session
Today's unusual volume stocks
| Ticker | Change | Comment |
|---|---|---|
| LYRA | -7.21% | LYRA THERAPEUTICS INC (NASDAQ:LYRA) has an unusual volume of 5.09M shares. Shares are witnessing a downward movement, with a decrease of 7.21%. With an average daily volume of 2.94M over the past 50 days, today's volume is 73.26% above the average, indicating a potential shift in market sentiment. |
| CETX | -3.41% | The trading activity for CEMTREX INC (NASDAQ:CETX) has surged with a volume of 1.29M shares today. This decline in share price leads to a decrease of 3.41%. In comparison to the average daily volume of the last 50 days, the current volume is 93.04% above. This suggests a notable change in trading activity. CEMTREX INC is releasing earnings today. |
| BENFW | -10.37% | The stock of BENEFICIENT CO GROUP -28 (NASDAQ:BENFW) has caught attention with a significant volume of 836.83K shares today. NASDAQ:BENFW is showing a decline of 10.37% in today's trading. With an average volume of 382.17K over the past 50 days, the current volume is 119.0% above the average. This deviation signals a potential shift in market dynamics. |
| JFBR | 6.93% | The trading activity for JEFFS BRANDS LTD (NASDAQ:JFBR) has surged with a volume of 1.54M shares today. The market is favoring NASDAQ:JFBR today, as its share price records a notable increase of 6.93%. The average volume over the last 50 days is 697.37K, making today's volume 121.0% above the average. This signifies a notable change in market participation. |
| NUWE | 0.23% | NUWELLIS INC (NASDAQ:NUWE) has an unusual volume of 7.97M shares today. The price of NASDAQ:NUWE has increased by 0.23%, indicating upward momentum in the market. The average daily volume over 50 days is 5.85M, so this is 36.15% above the average volume. |
| GRFX | -9.67% | The trading activity for GRAPHEX GROUP LTD-SPON ADR (NYSEARCA:GRFX) has surged with a volume of 1.28M shares today. This decline in share price leads to a decrease of 9.67%. The average daily volume over the past 50 days is 549.62K. Hence, the current volume is 134.0% above the average volume, indicating a deviation from the usual trading pattern. |
| GLYC | -1.1% | The trading activity for GLYCOMIMETICS INC (NASDAQ:GLYC) has surged with a volume of 2.19M shares today. NASDAQ:GLYC is declining 1.1% today. This is 43.3% above the average daily volume of the last 50 days. GLYCOMIMETICS INC is releasing earnings today. |
| MI | 3.29% | NFT LTD-A (NYSEARCA:MI) has an unusual volume of 758.68K shares today. The share price of NYSEARCA:MI increased by 3.29% today, reflecting positive market movement. The current trading volume is 21.53% above the average 50-day volume. This indicates a significant deviation from the average trading activity. |
| HSDT | -2.11% | HELIUS MEDICAL TECHNOLOGIES (NASDAQ:HSDT) has an unusual volume of 1.2M shares today. NASDAQ:HSDT is experiencing a downward trend, with a decline of 2.11%. With an average daily volume of 616.94K over the past 50 days, today's volume is 94.9% above the average, indicating a potential shift in market sentiment. HELIUS MEDICAL TECHNOLOGIES is releasing earnings today. |
| PRFT | 0.25% | The trading activity for PERFICIENT INC (NASDAQ:PRFT) has surged with a volume of 993.32K shares today. The share price of NASDAQ:PRFT increased by 0.25% today, reflecting positive market movement. This volume is 55.3% above the average 50 day volume. |
Our unusual volume stocks screener will show you the full list.
GLYCOMIMETICS INC
NASDAQ:GLYC (5/31/2024, 7:00:00 PM)
After market: 0.2779 +0.01 (+2.55%)0.271
0 (-1.09%)
GLYC News
3 days ago - GlycoMimetics, Inc.GlycoMimetics to Host Key Opinion Leader Event to Review Comprehensive Results from Pivotal Phase 3 Study of Uproleselan in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) on June 4, 2024
22 days ago - InvestorPlaceGLYC Stock Earnings: GlycoMimetics Misses EPS for Q1 2024GLYC stock results show that GlycoMimetics missed analyst estimates for earnings per share the first quarter of 2024.
22 days ago - BusinessInsiderGLYC Stock Earnings: GlycoMimetics Misses EPS for Q1 2024InvestorPlace - Stock Market News, Stock Advice & Trading Tips GlycoMimetics (NASDAQ:GLYC) just reported results for the first quarter of 2024...
a month ago - InvestorPlaceWhy Is Acutus Medical (AFIB) Stock Down 41% Today?Acutus Medical stock is down on Monday after the company reported a delisting notice that will hit AFIB shares later this week.
a month ago - InvestorPlaceWhy Is GlycoMimetics (GLYC) Stock Down 77% Today?GlycoMimetics stock is falling on Monday with heavy trading of GLYC after posting lackluster results from a Phase 3 trial of uproleselan.
a month ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on MondayIt's time to dive into the biggest pre-market stock movers with all of the hottest news worth reading about on Monday morning!
a month ago - GlycoMimetics, Inc.GlycoMimetics Announces Results of Pivotal Phase 3 Study of Uproleselan in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)
a month ago - GlycoMimetics, Inc.GlycoMimetics to Report First Quarter 2024 Financial Results on May 9, 20242 months ago - InvestorPlaceGLYC Stock Earnings: GlycoMimetics Beats EPS for Q4 2023GLYC stock results show that GlycoMimetics beat analyst estimates for earnings per share the fourth quarter of 2023.
2 months ago - BusinessInsiderGLYC Stock Earnings: GlycoMimetics Beats EPS for Q4 2023InvestorPlace - Stock Market News, Stock Advice & Trading Tips GlycoMimetics (NASDAQ:GLYC) just reported results for the fourth quarter of 202...
2 months ago - GlycoMimetics, Inc.GlycoMimetics Reports Highlights and Financial Results for Fourth Quarter and Full Year 2023
